Makoto Life Sciences, Inc. specializes in the identification of the targets of pharmaceutically active small molecules and the elucidation of their mechanisms of action. The Company has developed a unique multi-modal approach to target ID that combines genetic, biochemical and chemical methods. This approach has been developed and implemented by a team of dedicated Makoto scientists representing expertise in high-throughput biology, cell biology, biochemistry, and organic chemistry.
Makoto was founded in 2005 by world-renowned scientists associated with Harvard University and the Harvard Medical School. The Company currently employs 17 people and is located in Bedford MA, just outside of Boston.